🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone...
Status
Active Not Recruiting
Location
Ironwood Cancer & Res Ctr /ID# 222162
Start Date
2020-08-31
Trial ID
NCT04468984
Treatments Being Tested
Introduction. Despite the advantages associated with the use of remifentani...
Status
Completed
Location
Santa Lucinda Hospital
Start Date
2016-06-20
Trial ID
NCT03045133
The aim of the present trial is to evaluate the efficacy of PRF with 1% MF ...
Status
Completed
Location
Government Dental College and Research Institute
Start Date
2015-09
Trial ID
NCT03207698
The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
Status
Completed
Location
Telethon Kids Institute
Start Date
2021-01-11
Trial ID
NCT04545515
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of or...
Status
Completed
Location
Mayo Clinic Scottsdale Recruiting
Start Date
2011-06
Trial ID
NCT01423851
Treatments Being Tested
Cutaneous lymphoproliferative diseases (CLPDs) are a group of skin disorder...
Status
Active Not Recruiting
Location
Kasr Al-Aini Hospitals, Cairo University
Start Date
2026-01-01
Trial ID
NCT07705386
Treatments Being Tested
Correlation between optical coherence tomography and multifocal electroreti...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-20
Trial ID
NCT07171541
Treatments Being Tested
This study will assess safety as well as establish a Recommended Phase II d...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11-01
Trial ID
NCT01433445
Treatments Being Tested
A single-arm, non-randomized, multi-center clinical study of the Amplatzer™...
Status
Completed
Location
CHU Trousseau
Start Date
2020-09-14
Trial ID
NCT04433520
This phase II trial studies how well second mitochondrial-derived activator...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2014-12-18
Trial ID
NCT02098161
Treatments Being Tested